Q2 2025 Guidance — Pull-Through Weighted Rate Lock Volume: $5.5 billion to $8 billion for Q2 2025, indicating expected ...

Q1 2025 earnings call highlights progress on scaling sulfide electrolyte production, strong SK On collaboration, and fiscal discipline.

Marcus Theatres saw losses in the March quarter grow on a softer box office and higher costs before 'A Minecraft Movie' and ...

The Indian smartphone market declined 7% YoY in Q1 2025, driven by changing consumer preferences and competition. Premium and ...

Delays in monetizing non-core assets like the Flower Mart and Santa Fe Summit land parcels.

The Board of Directors of Extendicare today declared a cash dividend of $0.042 per share for the month of May 2025, which is payable on June 16, 2025, to shareholders of record at the close of ...

The EV startup beat Q1 earnings views with another quarter of gross profit, but cut delivery targets amid Trump tariffs.

Lucid Motors (LCID) reported first-quarter earnings on Tuesday, reaffirming its plans to more than double EV production in 2025.

Prestige Healthcare has decided not to renew its lease with real estate investment trust (REIT) LTC Properties for seven of its 14 skilled nursing ...

Electronic Arts announced strong preliminary results for its fiscal fourth quarter and fiscal year ended March 31, 2025. EA CEO Andrew Wilson said in a statement said that EA Sports College Football ...

Q1 2025 Management View CEO John Turner highlighted Atlas Energy's Q1 2025 revenue of $297.6 million and adjusted EBITDA of $74.3 million, reflecting a 25% margin. The results were slightly impacted ...

Investing.com -- Vera Therapeutics , Inc. (NASDAQ: VERA) reported a wider-than-expected loss for the first quarter of 2025, sending its shares down 2.9% in after-hours trading.